Tower Research Capital (TRC)’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $703 | Sell |
127
-29
| -19% | -$161 | ﹤0.01% | 4958 |
|
|
2025
Q1 | $898 | Buy |
156
+101
| +184% | +$581 | ﹤0.01% | 4808 |
|
|
2024
Q4 | $508 | Buy |
+55
| New | +$508 | ﹤0.01% | 5250 |
|
|
2024
Q3 | – | Sell |
-102
| Closed | -$1.95K | – | 5906 |
|
|
2024
Q2 | $1.95K | Sell |
102
-88
| -46% | -$1.68K | ﹤0.01% | 5072 |
|
|
2024
Q1 | $5.07K | Sell |
190
-484
| -72% | -$12.9K | ﹤0.01% | 4588 |
|
|
2023
Q4 | $9.22K | Buy |
674
+87
| +15% | +$1.19K | ﹤0.01% | 4422 |
|
|
2023
Q3 | $9.09K | Buy |
587
+282
| +92% | +$4.37K | ﹤0.01% | 4268 |
|
|
2023
Q2 | $6.58K | Sell |
305
-870
| -74% | -$18.8K | ﹤0.01% | 4658 |
|
|
2023
Q1 | $21K | Sell |
1,175
-586
| -33% | -$10.5K | ﹤0.01% | 3390 |
|
|
2022
Q4 | $30K | Buy |
1,761
+396
| +29% | +$6.75K | ﹤0.01% | 2748 |
|
|
2022
Q3 | $45K | Buy |
1,365
+684
| +100% | +$22.5K | ﹤0.01% | 3260 |
|
|
2022
Q2 | $38K | Sell |
681
-858
| -56% | -$47.9K | ﹤0.01% | 3145 |
|
|
2022
Q1 | $90K | Buy |
1,539
+1,256
| +444% | +$73.5K | ﹤0.01% | 2291 |
|
|
2021
Q4 | $20K | Sell |
283
-94
| -25% | -$6.64K | ﹤0.01% | 3675 |
|
|
2021
Q3 | $31K | Buy |
377
+162
| +75% | +$13.3K | ﹤0.01% | 3357 |
|
|
2021
Q2 | $21K | Buy |
215
+41
| +24% | +$4.01K | ﹤0.01% | 3850 |
|
|
2021
Q1 | $21K | Sell |
174
-320
| -65% | -$38.6K | ﹤0.01% | 3844 |
|
|
2020
Q4 | $65K | Sell |
494
-920
| -65% | -$121K | ﹤0.01% | 2821 |
|
|
2020
Q3 | $149K | Buy |
1,414
+1,219
| +625% | +$128K | ﹤0.01% | 2822 |
|
|
2020
Q2 | $50K | Buy |
195
+166
| +572% | +$42.6K | ﹤0.01% | 3047 |
|
|
2020
Q1 | $13K | Buy |
29
+21
| +263% | +$9.41K | ﹤0.01% | 1912 |
|
|
2019
Q4 | $6K | Sell |
8
-24
| -75% | -$18K | ﹤0.01% | 2603 |
|
|
2019
Q3 | $12K | Sell |
32
-499
| -94% | -$187K | ﹤0.01% | 2831 |
|
|
2019
Q2 | $96K | Buy |
+531
| New | +$96K | 0.01% | 1197 |
|